Steven Piver

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

BRCA1 Genes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
South Stacey A; Vance Heidi; Farrell Carolyn; DiCioccio Richard A; Fahey Cathy; Piver M Steven; Rodabaugh Kerry J
Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.
Piver M Steven
21st century challenge of ovarian cancer in the elderly. A personal perspective.
Ramus Susan J; Harrington Patricia A; Pye Carole; DiCioccio Richard A; Cox Mark J; Garlinghouse-Jones Kim; Oakley-Girvan Ingrid; Jacobs Ian J; Hardy Richard M; Whittemore Alice S; Ponder Bruce A J; Piver M Steven; Pharoah Paul D P; Gayther Simon A
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Steven Piver (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: South Stacey A; Vance Heidi; Farrell Carolyn; DiCioccio Richard A; Fahey Cathy; Piver M Steven; Rodabaugh Kerry J
Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.
Cancer 2009;115(2):324-33.
2008: Piver M Steven
21st century challenge of ovarian cancer in the elderly. A personal perspective.
Oncology (Williston Park, N.Y.) 2008;22(14):1580-5; discussion 1585, 1591-5.
2007: Ramus Susan J; Harrington Patricia A; Pye Carole; DiCioccio Richard A; Cox Mark J; Garlinghouse-Jones Kim; Oakley-Girvan Ingrid; Jacobs Ian J; Hardy Richard M; Whittemore Alice S; Ponder Bruce A J; Piver M Steven; Pharoah Paul D P; Gayther Simon A
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Human mutation 2007;28(12):1207-15.
2007: Ramus Susan J; Harrington Patricia A; Pye Carole; Peock Susan; Cook Margaret R; Cox Mark J; Jacobs Ian J; DiCioccio Richard A; Whittemore Alice S; Piver M Steven; EMBRACE; Easton Douglas F; Ponder Bruce A J; Pharoah Paul D P; Gayther Simon A
Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.
Human mutation 2007;28(5):525-6.
2006: Farrell Carolyn; Lyman Mollie; Freitag Katherine; Fahey Cathy; Piver M Steven; Rodabaugh Kerry J
The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(10):653-7.
2006: Piver M Steven
Treatment of ovarian cancer at the crossroads: 50 years after single-agent melphalan chemotherapy.
Oncology (Williston Park, N.Y.) 2006;20(10):1156, 1158.
2006: Villella Jeannine A; Parmar Madhu; Donohue Kathleen; Fahey Cathy; Piver M Steven; Rodabaugh Kerry
Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
Gynecologic oncology 2006;102(3):475-9.
2005: Piver M Steven
16,090: the 2004 estimated U.S. mortality from ovarian cancer.
Gynecologic oncology 2005;97(1):301-2.
2004: Whittemore A S; Balise R R; Pharoah P D P; Dicioccio R A; Oakley-Girvan I; Ramus S J; Daly M; Usinowicz M B; Garlinghouse-Jones K; Ponder B A J; Buys S; Senie R; Andrulis I; John E; Hopper J L; Piver M S
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
British journal of cancer 2004;91(11):1911-5.
2004: Piver M Steven
Management of early ovarian cancer.
Oncology (Williston Park, N.Y.) 2004;18(7):780; author reply 780.
2004: Werness Bruce A; Ramus Susan J; DiCioccio Richard A; Whittemore Alice S; Garlinghouse-Jones Kim; Oakley-Girvan Ingrid; Tsukada Yoshiaki; Harrington Patricia; Gayther Simon A; Ponder Bruce A J; Piver M Steven
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(1):29-34.
2003: Piver M Steven
Breast-cancer genomics.
The New England journal of medicine 2003;349(9):910-1; author reply 910-1.
2003: DiCioccio Richard A; Werness Bruce A; Piver M Steven
BRCA1 mutations.
Genes, chromosomes & cancer 2003;37(2):222.
2003: Ramus Susan J; Pharoah Paul D P; Harrington Patricia; Pye Carole; Werness Bruce; Bobrow Lynda; Ayhan Ayse; Wells Dagan; Fishman Ami; Gore Martin; DiCioccio Richard A; Piver M Steven; Whittemore Alice S; Ponder Bruce A J; Gayther Simon A
BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Cancer research 2003;63(2):417-23.
2002: Piver M Steven
Hereditary ovarian cancer. Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry.
Gynecologic oncology 2002;85(1):9-17.
2001: Eltabbakh G H; Natarajan N; Piver M S; Mettlin C J
Epidemiologic differences between women with colorectal cancer and women with ovarian cancer.
Journal of surgical oncology 2001;76(4):283-8.
2000: Werness B A; Ramus S J; Whittemore A S; Garlinghouse-Jones K; Oakley-Girvan I; Dicioccio R A; Tsukada Y; Ponder B A; Piver M S
Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
Human pathology 2000;31(11):1420-4.
2000: Werness B A; Ramus S J; Whittemore A S; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio R A; Tsukada Y; Ponder B A; Piver M S
Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(4):390-4.
2000: Piver M S; Tsukada Y; Werness B A; DiCioccio R A; Whittemore A S; Ponder B A
Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry.
Gynecologic oncology 2000;78(2):166-70.
2000: Werness B A; Parvatiyar P; Ramus S J; Whittemore A S; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio R A; Wiest J; Tsukada Y; Ponder B A; Piver M S
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Journal of the National Cancer Institute 2000;92(13):1088-91.
2000: Silver D F; Hempling R E; Piver M S; Repasky E A
Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice.
Gynecologic oncology 2000;77(3):377-82.
2000: Allen H J; DiCioccio R A; Hohmann P; Piver M S; Tworek H
Microsatellite instability in ovarian and other pelvic carcinomas.
Cancer genetics and cytogenetics 2000;117(2):163-6.
2000: Piver M S
The Gilda Radner Familial Ovarian Cancer Registry 1981-2000.
European journal of gynaecological oncology 2000;21(4):325-33.
1999: Werness B A; Freedman A N; Piver M S; Romero-Gutierrez M; Petrow E
Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
Gynecologic oncology 1999;75(3):413-8.
1999: Eltabbakh G H; Piver M S; Hempling R E; Recio F O
Laparoscopic surgery in obese women.
Obstetrics and gynecology 1999;94(5 Pt 1):704-8.
1999: Werness B A; Afify A M; Eltabbakh G H; Huelsman K; Piver M S; Paterson J M
p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1999;18(4):338-43.
1999: Silver D F; Piver M S
Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneum.
American journal of clinical oncology 1999;22(5):450-2.
1999: Eltabbakh G H; Piver M S; Hempling R E; Recio F O; Paczos T
Analysis of failed and complicated laparoscopy on a gynecologic oncology service.
Gynecologic oncology 1999;74(3):477-82.
1999: Eltabbakh G H; Piver M S; Hempling R E; Recio F O; Paczos T
Laparoscopic management of women with a family history of ovarian cancer.
Journal of surgical oncology 1999;72(1):9-13.
1999: Fetzer S; Tworek H A; Piver M S; DiCioccio R A
Classification of IVS1-10T-->C as a polymorphism of BRCA1.
Cancer genetics and cytogenetics 1999;113(1):58-64.
1999: Tworek H; Peng R; Fetzer S; Werness B A; Piver M S; Allen H J; DiCioccio R A
Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
Cancer genetics and cytogenetics 1999;112(2):105-18.
1999: Eltabbakh G H; Natarajan N; Piver M S; Mettlin C J
Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer.
Gynecologic oncology 1999;74(1):103-7.
1999: Kayastha S; Freedman A N; Piver M S; Mukkamalla J; Romero-Guittierez M; Werness B A
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1073-6.
1999: Silver D F; Piver M S
Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect.
Gynecologic oncology 1999;73(2):280-4.
1999: Recio F O; Ghamande S; Hempling R E; Piver M S
Effective management of pelvic lymphocysts by laparoscopic marsupialization.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 1999;3(2):97-102.
1999: Wong C; Hempling R E; Piver M S; Natarajan N; Mettlin C J
Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
Obstetrics and gynecology 1999;93(3):372-6.
1999: Werness B A; Afify A M; Bielat K L; Eltabbakh G H; Piver M S; Paterson J M
Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer.
Human pathology 1999;30(2):151-7.
1999: Xu Y; Silver D F; Yang N P; Oflazoglu E; Hempling R E; Piver M S; Repasky E A
Characterization of human ovarian carcinomas in a SCID mouse model.
Gynecologic oncology 1999;72(2):161-70.
1999: Silver D F; Hempling R E; Piver M S; Repasky E A
Effects of IL-12 on human ovarian tumors engrafted into SCID mice.
Gynecologic oncology 1999;72(2):154-60.
1999: Eltabbakh G H; Piver M S; Hempling R E; Recio F O; Intengen M E
Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.
Journal of surgical oncology 1999;70(1):6-12.
1998: Eltabbakh G H; Piver M S; Hempling R E; Recio F O; Blumenson L E
Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.
Gynecologic oncology 1998;71(2):190-5.
1998: Wong C; DiCioccio R A; Allen H J; Werness B A; Piver M S
Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation.
Cancer genetics and cytogenetics 1998;107(1):21-7.
1998: Hempling R E; Piver M S; Eltabbakh G H; Recio F O
Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer.
American journal of clinical oncology 1998;21(5):447-51.
1998: Silver D F; Hempling R E; Piver M S; Recio F O; Eltabbakh G H
Stage I adenocarcinoma of the cervix: does lesion size affect treatment options and prognosis?
American journal of clinical oncology 1998;21(5):431-5.
1998: Eltabbakh G H; Piver M S; Hempling R E; Recio F O; Lele S B; Marchetti D L; Baker T R; Blumenson L E
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.
Gynecologic oncology 1998;70(3):392-7.
1998: Silver D F; Hempling R E; Recio F O; Piver M S; Eltabbakh G H
Complications related to indwelling caval catheters on a gynecologic oncology service.
Gynecologic oncology 1998;70(3):329-33.
1998: DiCioccio R A; Werness B A; Peng R; Allen H J; Piver M S
Correlation of TP53 mutations and p53 expression in ovarian tumors.
Cancer genetics and cytogenetics 1998;105(2):93-102.
1998: Fetzer S; Tworek H A; Piver M S; Dicioccio R A
An alternative splice site junction in exon 1a of the BRCA1 gene.
Cancer genetics and cytogenetics 1998;105(1):90-2.
1998: Goldberg J M; Piver M S; Hempling R E; Aiduk C; Blumenson L; Recio F O
Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality.
Annals of surgical oncology 1998;5(5):399-406.
1998: Eltabbakh G H; Piver M S; Hempling R E; Werness B A; Blumenson L E
Importance of lymph node metastases in primary peritoneal carcinoma.
Journal of surgical oncology 1998;68(3):144-8.
1998: Eltabbakh G H; Piver M S
Extraovarian primary peritoneal carcinoma.
Oncology (Williston Park, N.Y.) 1998;12(6):813-9; discussion 820, 825-6.
1998: Recio F O; Piver M S; Hempling R E; Driscoll D L
Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer.
Gynecologic oncology 1998;68(3):267-73.
1998: Eltabbakh G H; Piver M S; Natarajan N; Mettlin C J
Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer.
Obstetrics and gynecology 1998;91(2):254-9.
1998: Recio F O; Piver M S; Hempling R E; Eltabbakh G H; Hahn S
Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study.
International journal of radiation oncology, biology, physics 1998;40(2):411-4.
1998: Allen H J; Briceno C A; Piver M S
Assessment of family cancer history collection and utilization in patient care.
Community genetics 1998;1(4):237-42.
1998: Recio F O; Sahai Srivastava B I; Wong C; Hempling R E; Eltabbakh G H; Piver M S
The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
European journal of gynaecological oncology 1998;19(3):203-8.
1998: Piver M S; Eltabbakh G H; Hempling R E; Recio F O; Blumenson L E
Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer.
European journal of gynaecological oncology 1998;19(1):5-10.
1997: Piver M S; Eltabbakh G H; Hempling R E; Recio F O; Blumenson L E
Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
Gynecologic oncology 1997;67(2):141-6.
1997: Loree T R; Hempling R E; Eltabbakh G H; Recio F O; Piver M S
The inferior gluteal flap in the difficult vulvar and perineal reconstruction.
Gynecologic oncology 1997;66(3):429-34.
1997: Eltabbakh G H; Piver M S; Werness B A
Primary peritoneal adenocarcinoma metastatic to the brain.
Gynecologic oncology 1997;66(1):160-3.
1997: Eltabbakh G H; Piver M S; Hempling R E; Recio F O; Aiduk C
Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
Gynecologic oncology 1997;66(1):103-7.
1997: Goldberg J M; Piver M S; Jishi M F; Blumenson L
Age at onset of ovarian cancer in women with a strong family history of ovarian cancer.
Gynecologic oncology 1997;66(1):3-9.
1997: Hempling R E; Wesolowski J A; Piver M S
Second-look laparotomy in advanced ovarian cancer: a critical assessment of morbidity and impact on survival.
Annals of surgical oncology 1997;4(4):349-54.
1997: Hempling R E; Wong C; Piver M S; Natarajan N; Mettlin C J
Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.
Obstetrics and gynecology 1997;89(6):1012-6.
1997: Hempling R E; Eltabbakh G H; Piver M S; Recio F O; O'Neill C P
The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
American journal of clinical oncology 1997;20(3):315-8.
1997: Eltabbakh G H; Piver M S; Hempling R E; Shin K H
Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
International journal of radiation oncology, biology, physics 1997;38(2):373-80.
1997: Werness B A; DiCioccio R A; Piver M S
Identical, unique p53 mutations in a primary ovarian mucinous adenocarcinoma and a synchronous contralateral ovarian mucinous tumor of low malignant potential suggest a common clonal origin.
Human pathology 1997;28(5):626-30.
1997: Werness B A; Jobe J S; DiCioccio R A; Piver M S
Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(2):149-55.
1997: Cornelison T L; Natarajan N; Piver M S; Mettlin C J
Tubal ligation and the risk of ovarian carcinoma.
Cancer detection and prevention 1997;21(1):1-6.
1996: Recio F O; Piver M S; Hempling R E
Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (> or = 5 cm) stage IB2 cervical carcinoma: report of a pilot study.
Gynecologic oncology 1996;63(3):333-6.
1996: Goldberg J M; Piver M S; Hempling R E; Recio F O
Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer.
Gynecologic oncology 1996;63(3):312-7.
1996: Recio F O; Piver M S; Hempling R E; Driscoll D L
Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy.
Cancer 1996;78(10):2157-63.
1996: Fine B A; Piver M S; McAuley M; Driscoll D
The curative potential of radiation therapy in the treatment of primary vaginal carcinoma.
American journal of clinical oncology 1996;19(1):39-44.
1996: Piver M S; Goldberg J M; Tsukada Y; Mettlin C J; Jishi M F; Natarajan N
Characteristics of familial ovarian cancer: a report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry.
European journal of gynaecological oncology 1996;17(3):169-76.
1995: Cornelison T L; Baker T R; Piver M S; Driscoll D L
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Gynecologic oncology 1995;59(2):243-8.
1995: Jishi M F; Itnyre J H; Oakley-Girvan I A; Piver M S; Whittemore A S
Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry.
Cancer 1995;76(8):1416-21.
1995: Hempling R E; Piver M S; Baker T R
Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
American journal of clinical oncology 1995;18(4):282-6.
1995: Cornelison T L; Goldberg J M; Piver M S
Taxol and platinum chemotherapy in the treatment of pancreatic and jejunal carcinoma.
Journal of surgical oncology 1995;59(3):204-8.
1995: Fine B A; Hempling R E; Piver M S; Baker T R; McAuley M; Driscoll D
Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery.
International journal of radiation oncology, biology, physics 1995;31(4):717-23.
1994: Hempling R E; Piver M S; Baker T R; Bakshi S; Gilani S S
Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in ovarian cancer. A pilot study.
American journal of clinical oncology 1994;17(4):331-4.
1994: Baker T R; Piver M S; Hempling R E
Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma.
Cancer 1994;74(2):656-63.
1994: Piver M S; Recio F O; Baker T R; Driscoll D
Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
Cancer 1994;73(6):1693-8.
1994: Hempling R E; Piver M S; Baker T R; O'Neill Mullen C
Lack of activity of 5-fluorouracil plus mitomycin-C as salvage therapy in cisplatin-resistant epithelial ovarian cancer: results of a phase II trial.
European journal of gynaecological oncology 1994;15(3):165-9.
1993: Hicks M L; Piver M S; Mas E; Hempling R E; Mcauley M; Walsh D L
Intraoperative orthovoltage radiation therapy in the treatment of recurrent gynecologic malignancies.
American journal of clinical oncology 1993;16(6):497-500.
1993: Hicks M L; Hempling R E; Piver M S
Vulvar carcinoma with 0.5 mm of invasion and associated inguinal lymph node metastasis.
Journal of surgical oncology 1993;54(4):271-3.
1993: Hempling R E; Piver M S; Natarajan N; Baker T R; Thompson J M; Hicks M L; Mettlin C J
Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer.
Journal of surgical oncology 1993;54(1):38-44.
1993: Hicks M L; Piver M S; Puretz J L; Hempling R E; Baker T R; Mcauley M; Walsh D L
Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus.
International journal of radiation oncology, biology, physics 1993;26(4):607-11.
1993: Piver M S; Jishi M F; Tsukada Y; Nava G
Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.
Cancer 1993;71(9):2751-5.
1993: Piver M S; Baker T R; Jishi M F; Sandecki A M; Tsukada Y; Natarajan N; Mettlin C J; Blake C A
Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991.
Cancer 1993;71(2 Suppl):582-8.
1993: Baker T R; Piver M S; Hempling R E
The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma.
European journal of gynaecological oncology 1993;14(1):18-22.
1993: Allen H J; Sharma A; Ahmed H; Piver M S; Gamarra M
Galaptin and galaptin-binding glycoconjugates in serum and effusions of carcinoma patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1993;14(6):360-8.
1993: Baker T R; Piver M S; Hempling R E
Response to Taxol chemotherapy in resistant ovarian carcinoma.
European journal of gynaecological oncology 1993;14(6):449-54.
1992: Piver M S; Recio F O; Baker T R; Hempling R E
A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma.
Gynecologic oncology 1992;47(3):373-6.
1992: Piver M S; Malfetano J; Baker T R; Hempling R E
Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.
Gynecologic oncology 1992;46(3):357-60.
1992: Hicks M L; Piver M S
Conservative surgery plus adjuvant therapy for vulvovaginal rhabdomyosarcoma, diethylstilbestrol clear cell adenocarcinoma of the vagina, and unilateral germ cell tumors of the ovary.
Obstetrics and gynecology clinics of North America 1992;19(1):219-33.
1991: Fanning J; Alvarez P M; Tsukada Y; Piver M S
Cervical implantation metastasis by endometrial adenocarcinoma.
Cancer 1991;68(6):1335-9.
1991: Piver M S; Baker T R; Piedmonte M; Sandecki A M
Epidemiology and etiology of ovarian cancer.
Seminars in oncology 1991;18(3):177-85.
1991: Baker T R; Piver M S; Caglar H; Piedmonte M
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
American journal of clinical oncology 1991;14(3):246-50.
1991: Piver M S; Fanning J; Baker T R
Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
American journal of clinical oncology 1991;14(3):200-2.
1991: Allen H J; Gamarra M; Piver M S; Johnson E A
Characterization of glycoconjugates released in vitro by human ovarian carcinoma cells isolated from effusions.
Cancer biochemistry biophysics 1991;12(1):9-22.
1991: Allen H J; Gamarra M; Piver M S; Sharma A; Ahmed H; Johnson E A
Synthesis and release of cell surface-derived and sulfated lactosaminoglycans by human ovarian carcinoma cells.
Cancer biochemistry biophysics 1991;12(1):23-31.
1991: Handley D J; Matta K L; Piver M S; Diakun K R
Antigenic studies on an enzymatically sialylated carbohydrate: NeuAc(alpha 2-3)Gal(beta 1-3)[GlcNAc(beta 1-6)]GalNAc.
Immunological investigations 1991;20(1):21-32.
1991: Henion T; Handley D; Vargas F; Matta K L; Piver M S; Diakun K R
Antigenic studies on an enzymatically sialylated carbohydrate: NeuAc(alpha 2-3)Gal(beta 1-3)GalNAc.
Immunological investigations 1991;20(1):1-20.
1991: Fanning J; Piver M S
Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancer.
Obstetrics and gynecology 1991;77(2):278-80.
1991: Fanning J; Alvarez P M; Tsukada Y; Piver M S
Prognostic significance of the extent of cervical involvement by endometrial cancer.
Gynecologic oncology 1991;40(1):46-7.
1991: Chadha K C; Ambrus J L; Halpern J; Khalil M; Sayyid S; Piver M S; Hreshchyshyn M M
The interferon system in carcinoma of the cervix. Effect of radiation and chemotherapy.
Cancer 1991;67(1):87-90.
1991: Srivastava M D; Piver M S
An extremely elevated serum CA125 level in a Crohn's patient developing endometriosis and the establishment of a cell line (MD-E) from the endometrioma.
Journal of medicine 1991;22(3):133-44.
1990: Piver M S; Malfetano J; Hempling R E; Baker T R; Driscoll D L
Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary report.
Gynecologic oncology 1990;39(3):249-52.
1990: Rose P G; Piver M S; Tsukada Y
Fallopian tube cancer. The Roswell Park experience.
Cancer 1990;66(12):2661-7.
1990: Fanning J; Biddle W C; Goldrosen M; Crickard K; Crickard U; Piver M S; Foon K A
Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay.
Gynecologic oncology 1990;39(2):119-22.
1990: Piver M S; Hempling R E
A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma.
Cancer 1990;66(6):1133-8.
1990: Fanning J; Tsukada Y; Piver M S
Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma.
Gynecologic oncology 1990;37(1):47-50.
1990: Piver M S
Invasive cervical cancer in the 1990s.
Seminars in surgical oncology 1990;6(6):359-63.
1989: Piver M; Khalil M; Emrich L J
Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer.
Journal of surgical oncology 1989;42(2):120-5.
1989: Piver M S; Malfetano J; Baker T R; Lele S B; Marchetti D L
Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report.
Gynecologic oncology 1989;35(1):69-72.
1989: Rose P G; Piver M S; Batista E; Lau T S
Patient-controlled analgesia in gynecologic oncology. A comparative analysis.
The Journal of reproductive medicine 1989;34(9):651-4.
1989: Fanning J; Lettieri L; Piver M S
Fatal recurrent reexpansion pulmonary edema.
Obstetrics and gynecology 1989;74(3 Pt 2):495-7.
1989: Lele S B; Piver M S; Mang T S; Dougherty T J; Tomczak M J
Photodynamic therapy in gynecologic malignancies.
Gynecologic oncology 1989;34(3):350-2.
1989: Rose P G; Piver M S
Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease.
Journal of surgical oncology 1989;41(3):148-52.
1989: Allen H J; Gamarra M; Piver M S; Johnson E A
Synthesis and release of glycoconjugates in vitro by human ovarian carcinoma cells isolated from effusions.
Cancer biochemistry biophysics 1989;10(3):219-26.
1989: Lele S B; Piver M S
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Gynecologic oncology 1989;33(1):6-8.
1989: Rose P G; Piver M S; Tsukada Y; Lau T
Patterns of metastasis in uterine sarcoma. An autopsy study.
Cancer 1989;63(5):935-8.
1989: Allen H J; Gamarra M; Piver M S; Johnson E A
Synthesis and release of glycoconjugates bearing N-linked oligosaccharides by ovarian carcinoma cells isolated from effusions.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1989;10(2):95-102.
1988: Piver M S; Lele S B; Marchetti D L; Baker T R; Emrich L J; Hartman A B
Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(11):1679-84.
1988: Piver M S; Lele S B; Bakshi S; Parthasarathy K L; Emrich L J
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
American journal of clinical oncology 1988;11(5):515-9.
1988: Lele S B; Piver M S; Matharu J; Tsukada Y
Peritoneal papillary carcinoma.
Gynecologic oncology 1988;31(2):315-20.
1988: Piver M S; Lele S B; Marchetti D L; Emrich L J
Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
Journal of surgical oncology 1988;38(4):233-9.
1988: Piver M S; Lele S B; Marchetti D L; Baker T R; Tsukada Y; Emrich L J
The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(6):983-9.
1988: Piver M S
Progesterone therapy for malignant peritoneal cytology surgical stage I endometrial adenocarcinoma.
Seminars in oncology 1988;15(2 Suppl 1):50-2.
1988: Piver M S; Rose P G
Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy.
Obstetrics and gynecology 1988;71(3 Pt 2):435-7.
1988: Piver M S; Moyer M; Diakun K; Lele S B; Chu T M
Serum alpha 1-acid glycoprotein in epithelial ovarian cancer.
Gynecologic oncology 1988;29(3):305-8.
1988: Piver M S; Marchetti D L; Patton T; Halpern J; Blumenson L; Driscoll D L
Radical hysterectomy and pelvic lymphadenectomy versus radiation therapy for small (less than or equal to 3 cm) stage IB cervical carcinoma.
American journal of clinical oncology 1988;11(1):21-4.
1988: Baker T R; Piver M S; Lele S B; Tsukada Y
Stage I uterine adenosarcoma: a report of six cases.
Journal of surgical oncology 1988;37(2):128-32.
1988: Piver M S; Lele S B; Gamarra M
Malignant peritoneal cytology in stage I endometrial adenocarcinoma: the effect of progesterone therapy (a preliminary report).
European journal of gynaecological oncology 1988;9(3):187-90.
1988: Piver M S; Lele S B; Baker T R; Sandecki A
Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
Cancer detection and prevention 1988;11(3-6):197-202.
1987: Piver M S; Lele S B; Patsner B; McPhee M E
1.5-5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer.
Gynecologic oncology 1987;27(1):24-33.
1987: Piver M S; Lele S B; Malfetano J H
cis-Diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer.
Gynecologic oncology 1987;26(1):71-6.
1987: Allen H J; Porter C; Gamarra M; Piver M S; Johnson E A
Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions.
Experimental cell biology 1987;55(4):194-208.
1987: Allen H J; Karakousis C; Piver M S; Gamarra M; Nava H; Forsyth B; Matecki B; Jazayeri A; Sucato D; Kisailus E
Galactoside-binding lectin in human tissues.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1987;8(4):218-29.
1986: Piver M S; Patton T
Ovarian cancer in children.
Seminars in surgical oncology 1986;2(3):163-9.
1985: Piver M S; Marchetti D L; Parthasarathy K L; Bakshi S; Reese P
Doxorubicin hydrochloride (Adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography.
Cancer 1985;56(1):76-80.
1983: Piver M S; Barlow J J; Lele S B; Malfetano J H; McPhee M E
Cis-diamminedichloroplatinum (II): second line induction chemotherapy in advanced ovarian adenocarcinoma.
Journal of surgical oncology 1983;24(4):329-31.
1982: Piver M S; Barlow J J; Lele S B; Bakshi S; Parthasarathy K L; Bender M A
Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma.
American journal of obstetrics and gynecology 1982;144(7):836-40.
1982: Lele S B; Piver M S; Barlow J J; Chatterjee S; Schneider S; Ip M
Comparison of cytosol estrogen receptor status in ovarian carcinoma using different radiolabeled ligands and methods.
Journal of surgical oncology 1982;21(3):155-8.
1980: Barlow J J; Piver M S; Lele S B
High-dose methotrexate with "RESCUE" plus cyclophosphamide as initial chemotherapy in ovarian adenocarcinoma. A randomized trial with observations on the influence of C parvum immunotherapy.
Cancer 1980;46(6):1333-8.
1980: Piver M S; Lele S B; Barlow J J; Gamarra M
Second-look laparoscopy prior to proposed second-look laparotomy.
Obstetrics and gynecology 1980;55(5):571-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Steven Piver

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Steven Piver (preview)

All Publications